The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1.
about
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing populationPlasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells.Curcumin inhibits advanced glycation end product-induced oxidative stress and inflammatory responses in endothelial cell damage via trapping methylglyoxal.Analysis of advanced glycation end products in the DHS Mind Study.Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage.Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.Methylglyoxal and glyoxalase I in atherosclerosis.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis.Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
P2860
Q26777077-3304CA2F-2D7D-4C67-8526-91000AE872E8Q33589073-445C8BB3-D1CD-4009-A781-DC5822434DD5Q34214122-AC77CA5B-6A1D-4F2F-9BCA-7D5996AA87D1Q36520256-6C353F2C-7C9C-4503-A8A8-31AA72FA37E6Q36600193-21D133CC-CD58-440D-8B04-01E807531392Q37631669-6854E9F0-D645-4F91-B850-7C659C1CA035Q37690997-7102A785-A0F0-42D8-9B77-19B41872CC0DQ38197343-77C458DF-F026-4715-972B-87B0997E5614Q38394355-C5E31CB0-109E-44D8-85B4-881E868499CEQ38620860-A1F49ABA-9AEE-4C54-AAFB-AB41A6F2A3B3Q38956425-087FF4D1-7FB5-461B-A740-10E8C2ACF339Q39083326-9D8A51FA-E15A-47D1-B015-F2FA8C126BB2Q39285661-9B073926-4990-4F48-87B7-55E7CB7BF916Q52716248-C5C7988A-9865-4AD7-AD73-5BC0D031A211Q53696915-C5DF09D0-3A56-4086-B216-347CE8E6FFF3Q55001495-F0451F07-06B6-4E30-89E1-C4B4D1A448B7
P2860
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The methylglyoxal-derived AGE ...... nd is associated with sVCAM-1.
@en
The methylglyoxal-derived AGE ...... nd is associated with sVCAM-1.
@nl
type
label
The methylglyoxal-derived AGE ...... nd is associated with sVCAM-1.
@en
The methylglyoxal-derived AGE ...... nd is associated with sVCAM-1.
@nl
prefLabel
The methylglyoxal-derived AGE ...... nd is associated with sVCAM-1.
@en
The methylglyoxal-derived AGE ...... nd is associated with sVCAM-1.
@nl
P2093
P2860
P50
P1433
P1476
The methylglyoxal-derived AGE ...... and is associated with sVCAM-1
@en
P2093
C D A Stehouwer
C G Schalkwijk
H H Parving
H W M Niessen
M G A van Eupen
N M J Hanssen
P2860
P2888
P304
P356
10.1007/S00125-013-2919-8
P577
2013-04-26T00:00:00Z